Company / Profit Margin
NovoCure Ltd Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-20.8%
FY2025
5-year range
-40.6% / -10.9%
FY2021-FY2025
Trend
+25.4%
vs FY2024
Sector context
#127 of 150
Health Care
What the data says
NovoCure Ltd's profit margin of -20.8% is lower than 85% of companies in the Health Care sector (FY2025). Improved from -40.6% to -20.8% over the past 2 years.
Based on SEC 10-K filings.
-20.8% in FY2025 with a 5-year CAGR of -24.8%.
Improved from -40.6% to -20.8% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -3.6pp
- 5-Year Change
- -24.8pp
- 10-Year Change
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 150This company -20.8% Sector average -263.0%
▼
+92.1% above sector average
Key checks
Key Insights
- In FY2025, profit margin increased 25.4% year-over-year.
- Currently 242.2pp above the Health Care sector average.
- Peak profit margin was recorded in FY2020.
- Lowest profit margin in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -20.8% | +25.4% |
| FY2024 | -27.9% | +31.5% |
| FY2023 | -40.6% | -136.3% |
| FY2022 | -17.2% | -57.7% |
| FY2021 | -10.9% | -372.1% |
| FY2020 | 4.0% | +294.7% |
| FY2019 | -2.1% | +92.0% |
| FY2018 | -25.6% | +26.4% |
| FY2017 | -34.8% | +78.1% |
| FY2016 | -159.1% | +52.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026